VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,883 | -16.9% | 252,701 | +12.6% | 0.00% | – |
| Q2 2023 | $316,457 | -11.3% | 224,438 | 0.0% | 0.00% | – |
| Q1 2023 | $356,856 | +109030.3% | 224,438 | 0.0% | 0.00% | – |
| Q4 2022 | $327 | -100.0% | 224,438 | +3.0% | 0.00% | – |
| Q3 2022 | $930,000 | +17.7% | 217,936 | +7.0% | 0.00% | – |
| Q2 2022 | $790,000 | -65.5% | 203,632 | -57.7% | 0.00% | – |
| Q1 2022 | $2,293,000 | +36.2% | 481,725 | +4.4% | 0.00% | – |
| Q4 2021 | $1,683,000 | -56.4% | 461,227 | -4.2% | 0.00% | -100.0% |
| Q3 2021 | $3,860,000 | -24.2% | 481,301 | +7.1% | 0.00% | 0.0% |
| Q2 2021 | $5,094,000 | +841.6% | 449,236 | +667.5% | 0.00% | – |
| Q1 2021 | $541,000 | – | 58,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,120,000 | 0.80% |
| Samsara BioCapital, LLC | 689,709 | $2,676,000 | 0.71% |
| BVF INC/IL | 3,614,662 | $14,025,000 | 0.68% |
| HAMILTON LANE ADVISORS LLC | 71,491 | $277,000 | 0.11% |
| MAI Capital Management | 647,950 | $2,514,000 | 0.05% |
| Laurion Capital Management LP | 698,000 | $2,708,000 | 0.04% |
| Jasper Ridge Partners, L.P. | 92,939 | $361,000 | 0.02% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $80,000 | 0.02% |
| Ergoteles LLC | 155,562 | $604,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 25,000 | $97,000 | 0.01% |